Arrayit Corporation Launches Patient Data Solutions Allergy Testing Portal for Doctors and Clinics
2018年10月22日 - 6:30PM
Sunnyvale, Oct. 22, 2018 (GLOBE NEWSWIRE) -- Arrayit Corporation
(OTC: ARYC), a life sciences and personalized medicine
company, launches a fully automated allergy testing portal for
doctors and clinics to streamline and accelerate the allergy
testing and treatment process. The Patient Data Solutions (PDS)
allergy-testing suite is secure and fully compliant with Health
Insurance Portability and Accountability Act (HIPAA) requirements
to ensure the privacy of patient health records. The new PDS portal
allows doctors to order allergy blood card collection kits, request
express mail shipping labels, download allergy test results, and
order immunotherapy products from our independent allergy
therapeutics partners. The PDS portal, which is free of charge to
doctors and clinics, offers continuous, real-time technical
assistance to ensure a positive on-line experience.
Arrayit recently completed an allergy testing pilot program for
a top retail chain, established a nationwide network of 1,700
allergy sales professionals, met with top officials at the United
States Food and Drug Administration (FDA) regarding approval of a
major product line, signed allergy testing contracts with a
consortium of 178 medical clinics, received approval for in-store
promotions by a major retailer, announced allergy testing
partnerships with major allergy therapeutics providers, received
approval for direct Medicare billing by the Centers for Medicare
and Medicaid Services (CMS), reported the sale and shipping of
clinical instrumentation to the FDA, and aced three consecutive
rounds of proficiency testing with the College of American
Pathologists. The PDS allergy-testing portal with its
enterprise-level functionality ensures the seamless onboarding and
servicing of physicians in private healthcare practices, allergy
clinics, hospitals, health maintenance organization (HMO)
facilities and in-store retail clinics.
Chief Executive Officer Rene Schena states, “The Patient Data
Solutions electronic suite gives doctors direct access to the
resources required for efficient, high-throughput allergy testing.
This enterprise scale solution highlights our commitment to
pioneering the market’s most advanced physician-directed strategies
for diagnosing and treating allergy and asthma.”
About Arrayit
Arrayit Corporation, headquartered in Sunnyvale, California, leads
and empowers the research, biotechnology, pharmaceutical, clinical
and healthcare sectors through the discovery, development and
manufacture of proprietary life science and personalized medicine
products and services to advance biomedical research and improve
wellness and human health. Please
visit www.arrayit.com for more information.
Safe Harbor Statement
We have identified forward-looking statements by using words such
as "expect", "believe", and "should". Although we believe our
expectations are reasonable, our operations involve a number of
risks and uncertainties that are beyond our control, and these
statements may turn out not to be true. Risk factors associated
with our business, including some of the facts set forth herein,
are detailed in the Company's public filings.
CONTACT
Public Relations
Arrayit Corporation
Tel: 408-744-1331
Email: arrayit@arrayit.com
Web: www.arrayit.com
CONTACT
Public Relations
Arrayit Corporation
Tel: 408-744-1331
Email: arrayit@arrayit.com
Web: www.arrayit.com
Arrayit (CE) (USOTC:ARYC)
過去 株価チャート
から 10 2024 まで 11 2024
Arrayit (CE) (USOTC:ARYC)
過去 株価チャート
から 11 2023 まで 11 2024
